Literature DB >> 11810683

Scan time reduction in proton magnetic resonance spectroscopic imaging of the human brain.

Xavier Golay1, Joseph Gillen, Peter C M van Zijl, Peter B Barker.   

Abstract

A simple technique is described for scan time reductions in proton magnetic resonance spectroscopic imaging (MRSI) of the human brain. Scan time is reduced by approximately 35% while preserving spatial resolution by reducing the field of view (FOV) and number of phase-encoding steps in the transverse direction of the brain. A multislice MRSI of the brain is demonstrated which takes approximately 20 min with a square FOV, and 13 min with a reduced FOV. The signal-to-noise ratio (SNR) in the reduced FOV scan was measured to be 15% lower than that of the full FOV scan, which is close to the expected theoretical value of 19% based on the square root of the scan time. The method can be applied with any sequence, and requires minimal software and no hardware modifications. Scan time in MRSI is minimized in this method by using FOVs no larger than the dimensions of the object to be imaged. The method may also be combined with other fast MRSI techniques to provide further scan time reductions. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11810683     DOI: 10.1002/mrm.10038

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  16 in total

Review 1.  MR spectroscopy and spectroscopic imaging of the brain.

Authors:  He Zhu; Peter B Barker
Journal:  Methods Mol Biol       Date:  2011

2.  Early characteristics of Sturge-Weber syndrome shown by perfusion MR imaging and proton MR spectroscopic imaging.

Authors:  Doris D M Lin; Peter B Barker; Michael A Kraut; Anne Comi
Journal:  AJNR Am J Neuroradiol       Date:  2003-10       Impact factor: 3.825

Review 3.  Parallel magnetic resonance imaging.

Authors:  Ulrich Katscher; Peter Börnert
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

4.  Fast parallel spiral chemical shift imaging at 3T using iterative SENSE reconstruction.

Authors:  Dirk Mayer; Dong-Hyun Kim; Daniel M Spielman; Roland Bammer
Journal:  Magn Reson Med       Date:  2008-04       Impact factor: 4.668

5.  Evaluation of magnetic resonance imaging for diagnostic purposes in operative dentistry-a systematic review.

Authors:  Silwan Mendes; Carin A Rinne; Julia C Schmidt; Dorothea Dagassan-Berndt; Clemens Walter
Journal:  Clin Oral Investig       Date:  2019-12-10       Impact factor: 3.573

6.  Neuroimaging and neuropsychological follow-up study in a pediatric brain tumor patient treated with surgery and radiation.

Authors:  Adam T Schmidt; Rebecca B Martin; Arzu Ozturk; Wendy R Kates; Moody D Wharam; E Mark Mahone; Alena Horska
Journal:  Neurocase       Date:  2010-02       Impact factor: 0.881

7.  Water removal in MR spectroscopic imaging with L2 regularization.

Authors:  Liangjie Lin; Michal Považan; Adam Berrington; Zhong Chen; Peter B Barker
Journal:  Magn Reson Med       Date:  2019-05-31       Impact factor: 4.668

8.  Volumetric spiral chemical shift imaging of hyperpolarized [2-(13) c]pyruvate in a rat c6 glioma model.

Authors:  Jae Mo Park; Sonal Josan; Taichang Jang; Milton Merchant; Ron Watkins; Ralph E Hurd; Lawrence D Recht; Dirk Mayer; Daniel M Spielman
Journal:  Magn Reson Med       Date:  2015-05-06       Impact factor: 4.668

9.  Dynamic metabolic imaging of hyperpolarized [2-(13) C]pyruvate using spiral chemical shift imaging with alternating spectral band excitation.

Authors:  Sonal Josan; Ralph Hurd; Jae Mo Park; Yi-Fen Yen; Ron Watkins; Adolf Pfefferbaum; Daniel Spielman; Dirk Mayer
Journal:  Magn Reson Med       Date:  2013-07-22       Impact factor: 4.668

10.  Classification of childhood white matter disorders using proton MR spectroscopic imaging.

Authors:  A Bizzi; G Castelli; M Bugiani; P B Barker; E H Herskovits; U Danesi; A Erbetta; I Moroni; L Farina; G Uziel
Journal:  AJNR Am J Neuroradiol       Date:  2008-05-15       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.